Kuangli Bio-Tech Holdings Co., Ltd. (6431.TW) Stock
—
Valuation
Financials & Margins
Valuation & Return Ratios
Ownership
Peer Comparison
About Kuangli Bio-Tech Holdings Co., Ltd.
—
Kuangli Bio-Tech Holdings Co., Ltd. is led by CEO Ching Lien Chang, employs 180 people, headquartered in Grand Cayman, KY, publicly traded since 2014.
Kuangli Bio-Tech Holdings Co., Ltd. (6431.TW) stock trades at $15.10 with a market capitalization of $1.59B. The stock is valued at a negative price-to-earnings (P/E) ratio of -8.33, reflecting a net loss over the last twelve months, price-to-book of 3.14, price-to-sales of 4.37. Over the past 52 weeks the stock has ranged between $15.00 and $32.00, and currently trades 52.8% below its 52-week high.
On profitability, Kuangli Bio-Tech Holdings Co., Ltd. generates a return on equity (ROE) of -33.41% (negative, reflecting a net loss), an operating margin of -45.39%, a net profit margin of -53.13%.
Official website: www.kskl.com.cn
Kuangli Bio-Tech Holdings Co., Ltd. (6431.TW) — frequently asked questions
What is Kuangli Bio-Tech Holdings Co., Ltd. (6431.TW) stock price today?
Kuangli Bio-Tech Holdings Co., Ltd. (6431.TW) is currently trading at $15.10, down 7.36% today.
What is 6431.TW P/E ratio?
Kuangli Bio-Tech Holdings Co., Ltd.'s P/E ratio is -8.33. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is 6431.TW return on equity (ROE)?
Kuangli Bio-Tech Holdings Co., Ltd.'s return on equity (ROE) is -33.41%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Kuangli Bio-Tech Holdings Co., Ltd.'s market cap?
Kuangli Bio-Tech Holdings Co., Ltd. has a market capitalization of $1.59B.
Does 6431.TW pay a dividend?
Kuangli Bio-Tech Holdings Co., Ltd. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does 6431.TW carry?
Kuangli Bio-Tech Holdings Co., Ltd. has a debt-to-equity ratio of 0.99. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 6431.TW's profit margin?
Kuangli Bio-Tech Holdings Co., Ltd. reports a net profit margin of -53.13% — the share of revenue left after every cost, including tax and interest.
What sector is 6431.TW in?
Kuangli Bio-Tech Holdings Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 6431.TW listed on?
Kuangli Bio-Tech Holdings Co., Ltd. trades on TAI under the ticker 6431.TW.
What is 6431.TW's 52-week range?
Over the last year Kuangli Bio-Tech Holdings Co., Ltd. has traded between $15.00 and $32.00.
Related — Stocks
Popular Stocks
Screens 6431.TW currently matches
On the figures above, Kuangli Bio-Tech Holdings Co., Ltd. passes the filters for 5 of our ready-made screens, among them Day Losers Stocks, Small Cap Stocks, Stocks Under $100. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.